Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apellis Pharmaceuticals Inc COM | 11,890,843 | 11,895,808 | +4,965 | $379.44M | $260.16M | 15.45% | -$119.28M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 1,706,469 | 1,706,469 | 0 | $210.15M | $211.86M | 12.58% | +$1.71M |
| Zymeworks Inc.(ZYME) | 15,028,079 | 17,259,548 | +2,231,469 | $220.01M | $205.56M | 12.21% | -$14.45M |
| Anaptysbio Inc | 7,873,448 | 7,880,094 | +6,646 | $104.24M | $146.49M | 8.70% | +$42.25M |
| Crinetics Pharmaceuticals In | 4,288,120 | 4,288,120 | 0 | $219.25M | $143.82M | 8.54% | -$75.43M |
| Prothena Corp PlcSHS SHS | 11,584,280 | 11,584,280 | 0 | $160.44M | $143.36M | 8.51% | -$17.09M |
| Sarepta Therapeutics, Inc.(SRPT) | 770,000 | 1,292,386 | +522,386 | $93.62M | $82.48M | 4.90% | -$11.14M |
| Xencor, Inc.(XNCR) | 6,144,767 | 6,144,767 | 0 | $141.21M | $65.38M | 3.88% | -$75.83M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 1,389,276 | 1,389,276 | 0 | $54.68M | $47.28M | 2.81% | -$7.40M |
| uniQure N.V.SHS(QURE) | 3,400,000 | 3,988,971 | +588,971 | $60.04M | $42.28M | 2.51% | -$17.76M |
| Janux Therapeutics, Inc.(JANX) | 1,469,818 | 1,469,818 | 0 | $78.69M | $39.69M | 2.36% | -$39.01M |
| Immunome, Inc.(IMNM) | 3,879,415 | 4,079,415 | +200,000 | $41.20M | $27.45M | 1.63% | -$13.74M |
| Eton Pharmaceuticals, Inc.(ETON) | 1,829,603 | 1,939,288 | +109,685 | $24.37M | $25.17M | 1.49% | +$801.6K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 75,000 | 75,000 | 0 | $23.14M | $24.84M | 1.48% | +$1.70M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 3,418,068 | 3,418,068 | 0 | $27.58M | $19.07M | 1.13% | -$8.51M |
| Akero Therapeutics Inc | 0 | 440,000 | +440,000 | $0 | $17.81M | 1.06% | +$17.81M |
| Kura Oncology, Inc.(KURA) | 3,557,269 | 2,640,298 | -916,971 | $30.98M | $17.43M | 1.03% | -$13.56M |
| Tectonic Therapeutic, Inc.(TECX) | 849,143 | 935,121 | +85,978 | $39.20M | $16.56M | 0.98% | -$22.64M |
| Avidity Biosciences Inc | 557,576 | 557,576 | 0 | $16.21M | $16.46M | 0.98% | +$245.3K |
| Neurogene Inc.(NGNE) | 1,271,342 | 1,271,342 | 0 | $29.06M | $14.89M | 0.88% | -$14.18M |
| Tango Therapeutics, Inc.(TNGX) | 10,630,736 | 10,630,736 | 0 | $32.85M | $14.56M | 0.86% | -$18.28M |
| Voyager Therapeutics, Inc.(VYGR) | 3,917,546 | 3,917,546 | 0 | $22.21M | $13.24M | 0.79% | -$8.97M |
| Beam Therapeutics Inc.(BEAM) | 0 | 526,685 | +526,685 | $0 | $10.29M | 0.61% | +$10.29M |
| MBX Biosciences, Inc.(MBX) | 1,259,273 | 1,259,273 | 0 | $23.21M | $9.29M | 0.55% | -$13.91M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 1,743,344 | 1,462,328 | -281,016 | $17.12M | $8.34M | 0.49% | -$8.78M |
| Replimune Group, Inc.(REPL) | 850,341 | 850,341 | 0 | $10.30M | $8.29M | 0.49% | -$2.01M |
| Bicycle Therapeutics PlcADS | 910,000 | 910,000 | 0 | $12.74M | $7.73M | 0.46% | -$5.01M |
| Day One Biopharmaceuticals I COM | 862,068 | 862,068 | 0 | $10.92M | $6.84M | 0.41% | -$4.09M |
| Verve Therapeutics Inc | 1,250,000 | 1,250,000 | 0 | $7.05M | $5.71M | 0.34% | -$1.34M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 27,404,070 | 27,404,070 | 0 | $14.76M | $5.40M | 0.32% | -$9.36M |
| Lakefront Biotherapeutics NVADR(LKFT) | 155,006 | 155,006 | 0 | $4.26M | $3.89M | 0.23% | -$368.9K |
| Whitehawk Therapeutics, Inc.(WHWK) | 345,253 | 2,082,000 | +1,736,747 | $1.09M | $3.71M | 0.22% | +$2.62M |
| Atara Biotherapeutics Inc | 532,134 | 573,183 | +41,049 | $7.08M | $3.40M | 0.20% | -$3.68M |
| Solid Biosciences Inc | 0 | 744,450 | +744,450 | $0 | $2.75M | 0.16% | +$2.75M |
| Keros Therapeutics, Inc.(KROS) | 187,500 | 187,500 | 0 | $2.97M | $1.91M | 0.11% | -$1.06M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 963,333 | 963,333 | 0 | $2.56M | $1.70M | 0.10% | -$867.0K |
| Relay Therapeutics, Inc.(RLAY) | 641,426 | 641,426 | 0 | $2.64M | $1.68M | 0.10% | -$962.1K |
| Kalaris Therapeutics, Inc.(KLRS) | 0 | 201,718 | +201,718 | $0 | $1.62M | 0.10% | +$1.62M |
| Prime Medicine, Inc.(PRME) | 700,000 | 700,000 | 0 | $2.04M | $1.39M | 0.08% | -$651.0K |
| Metsera Inc | 0 | 50,000 | +50,000 | $0 | $1.36M | 0.08% | +$1.36M |
| TScan Therapeutics, Inc.(TCRX) | 5,000,000 | 662,833 | -4,337,167 | $15.20M | $914.7K | 0.05% | -$14.29M |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 66,665 | 66,665 | 0 | $956.6K | $777.3K | 0.05% | -$179.3K |
| Aligos Therapeutics, Inc.(ALGS) | 255,573 | 88,569 | -167,004 | $10.18M | $730.7K | 0.04% | -$9.45M |
| Upstream Bio, Inc.(UPB) | 60,000 | 60,000 | 0 | $986.4K | $367.2K | 0.02% | -$619.2K |
| Allovir Inc | 408,688 | 0 | -408,688 | $3.95M | $0 | — | -$3.95M |
| Artiva Biotherapeutics, Inc.(ARTV) | 41,453 | 0 | -41,453 | $417.8K | $0 | — | -$417.8K |
| Arvinas, Inc.(ARVN) | 6,726,491 | 0 | -6,726,491 | $128.95M | $0 | — | -$128.95M |
| Atea Pharmaceuticals, Inc.(AVIR) | 3,341,653 | 0 | -3,341,653 | $11.19M | $0 | — | -$11.19M |
| Cargo Therapeutics Inc | 1,470,000 | 0 | -1,470,000 | $21.20M | $0 | — | -$21.20M |
| Design Therapeutics, Inc.(DSGN) | 426,683 | 0 | -426,683 | $2.63M | $0 | — | -$2.63M |
| Dyne Therapeutics, Inc.(DYN) | 555,644 | 0 | -555,644 | $13.09M | $0 | — | -$13.09M |
| Fate Therapeutics, Inc.(FATE) | 3,049,405 | 0 | -3,049,405 | $5.03M | $0 | — | -$5.03M |
| Generation Bio Co | 2,046,867 | 0 | -2,046,867 | $2.17M | $0 | — | -$2.17M |
| Hookipa Pharma Inc | 388,861 | 0 | -388,861 | $781.6K | $0 | — | -$781.6K |
| Kymera Therapeutics, Inc.(KYMR) | 350,000 | 0 | -350,000 | $14.08M | $0 | — | -$14.08M |
| Mersana Therapeutics Inc | 11,328,000 | 0 | -11,328,000 | $16.20M | $0 | — | -$16.20M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 332,522 | 0 | -332,522 | $18.01M | $0 | — | -$18.01M |
| Neumora Therapeutics, Inc.(NMRA) | 2,071,450 | 0 | -2,071,450 | $21.96M | $0 | — | -$21.96M |
| Springworks Therapeutics Inc | 1,560,000 | 0 | -1,560,000 | $56.36M | $0 | — | -$56.36M |
| Third Harmonic Bio Inc | 3,182,444 | 0 | -3,182,444 | $32.75M | $0 | — | -$32.75M |